Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 17, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.6K

Cost-Effectiveness Methods and Newborn Screening Assessment.

I Castilla-Rodríguez1,2,3, L Vallejo-Torres4,5,6, M L Couce7,8

  • 1Departamento de Ingeniería Informática y de Sistemas, Universidad de La Laguna, La Laguna, Spain. icasrod@ull.es.

Advances in Experimental Medicine and Biology
|December 8, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychological functions as trait markers in OCD: A 10-year follow-up study.

Comprehensive psychiatry·2026
Same author

Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study.

Vaccine·2023
Same author

Brief cognitive tests as a decision-making tool in primary care. A population and validation study.

Neurologia·2022
Same author

Validity of a computerised population registry of dementia based on clinical databases.

Neurologia·2021
Same author

Effectiveness of a decision aid for patients with knee osteoarthritis: a randomized controlled trial.

Osteoarthritis and cartilage·2021
Same author

Sleep disorders in phenylketonuria.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2019
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles
This summary is machine-generated.

Evaluating the cost-effectiveness of newborn screening for rare diseases presents significant challenges. Standard economic evaluation methods face limitations due to data scarcity and the inherent nature of rare conditions, requiring careful consideration.

Area of Science:

  • Health Economics
  • Public Health
  • Genetics

Background:

  • Health funding decisions require robust effectiveness and economic evidence.
  • Newborn screening for rare diseases has been implemented for over 50 years.
  • Economic evaluation of these programs remains a complex challenge.

Purpose of the Study:

  • To review current economic evaluation methods for health interventions.
  • To identify challenges in applying these methods to newborn screening programs.
  • To discuss the conceptual and methodological limitations in assessing cost-effectiveness.

Main Methods:

  • Literature review of economic evaluation frameworks.
  • Analysis of challenges specific to rare disease screening.
  • Discussion of evidence generation for cost-effectiveness.
Keywords:
Newborn screening; Cost-effectiveness analysis; Cost-utility analysis; Economic evaluation; Biotinidase deficiency; Quality-adjusted life years

More Related Videos

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.1K

Related Experiment Videos

Last Updated: Feb 17, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.6K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.1K

Main Results:

  • Standard economic evaluation methods face validity issues in newborn screening.
  • The rarity of target conditions limits the collection of robust evidence.
  • Conceptual and methodological limitations complicate cost-effectiveness assessments.

Conclusions:

  • Assessing the economic value of newborn screening requires tailored approaches.
  • Addressing data limitations and methodological challenges is crucial for informed funding decisions.
  • Further research is needed to refine economic evaluation frameworks for rare disease screening programs.